World News
-
Merck buys Tilos Therapeutics in a $773M deal
World | News | 0 Comment | 13 Jun, 2019
Merck known as MSD outside the United States and Canada has announced that it has entered into a definitive agreement to acquire Tilos Therapeutics, a privately held biopharmaceutical compa...Read more
-
Dulaglutide reduces cardiovascular disease in Type-2 diabetic people
World | News | 0 Comment | 10 Jun, 2019
The Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) trial has found dulaglutide, an injectable, glucagon-like peptide-1 (GLP-1) receptor agonist, dem...Read more
-
Thermo Fisher Scientific acquires HighChem
World | News | 0 Comment | 10 Jun, 2019
Thermo Fisher Scientific, the world leader in serving science has recently announced that it has completed the acquisition of HighChem, Ltd., a leading developer of mass spectrometry softwa...Read more
-
Thermo Scientific launches Rheometer series for quality control labs
World | News | 0 Comment | 10 Jun, 2019
The Thermo Scientific HAAKE MARS iQ Rheometer was specifically designed to meet the needs of QC labs with built-in features that assist users to deliver more reliable results. Key features ...Read more
-
Labcorp, QIAGEN announce companion diagnostic for metastatic breast cancer
World | News | 0 Comment | 11 Jun, 2019
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care has announced a new companion diagnostic called therascreen PIK3CA PCR...Read more
-
PTC gets FDA nod for the expansion of the EMFLAZA® labeling
World | News | 0 Comment | 10 Jun, 2019
PTC Therapeutics is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits ...Read more
-
FDA approves new treatment for hospital acquired infections
World | News | 0 Comment | 10 Jun, 2019
The U.S. Food and Drug Administration has approved a new indication for the previously FDA-approved drug, Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacteri...Read more
-
First patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia
World | News | 0 Comment | 07 Jun, 2019
Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, announced on 4 June 2019, that the first patient has been dosed with its lead candidate, le...Read more
-
FSD Pharma adds two more prominent Cannabis researchers to Scientific Advisory Board
World | News | 0 Comment | 07 Jun, 2019
FSD Pharma Inc. has announced the addition of two distinguished cannabis researchers to the company’s Scientific Advisory Board. “It is with great pride tha...Read more
-
PhoenixMD and WuXi STA to Support Phase I/Ib Study of PMD-026 for TNBC
World | News | 0 Comment | 07 Jun, 2019
Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics targeting essential kinases, announces the completion of clinical trial s...Read more
-
DuPont Microbiome announces a strategic partnership with BioMe Oxford
World | News | 0 Comment | 07 Jun, 2019
The DuPont Microbiome Venture announces a strategic investment and partnership with BioMe Oxford Ltd. BioMe Oxford is an early stage startup located in Oxford, United Kingdom, which is deve...Read more
-
Philips, UVM Health Network sign pact to improve patient care
World | News | 0 Comment | 07 Jun, 2019
Royal Philips a global leader in health technology, and the University of Vermont (UVM) Health Network, a leading provider of quality care have announced a long-term, strategic partnership ...Read more
-
World | News | 0 Comment | 06 Jun, 2019
Eli Lilly and Company recently announced that the U.S. Food and Drug Administration has approved Emgality (galcanezumab-gnlm) injection (300 mg) for the treatment o...Read more
-
Bio-Techne to acquire B-MoGen Biotechnologies Inc.
World | News | 0 Comment | 06 Jun, 2019
Bio-Techne Corporation announced that it has reached agreement to acquire all of the stock of B-MoGen Biotechnologies Inc. The transaction has been completed and is being financed through a...Read more
-
Genentech announces meeting of primary endpoint of Ph III study
World | News | 0 Comment | 04 Jun, 2019
Genentech, a member of the Roche Group has announced that the Phase III BLOCKSTONE study, conducted by Shionogi & Co. Ltd. met its primary endpoint showing that people exposed to a...Read more
-
PromarkerD at BIO 2019 to diagnose future kidney disease status
World | News | 0 Comment | 04 Jun, 2019
Proteomics International will be at the 2019 BIO International Convention in Philadelphia (stand #2349) preparing for the US roll-out of PromarkerD, a blood test that can diagnose and predi...Read more
-
LEO Pharma appoints Catherine Mazzacco as new CEO
World | News | 0 Comment | 05 Jun, 2019
LEO Pharma, a leader in medical dermatology has announced that Gitte Aabo will step down as President and CEO after 27 years in the company, 11 of these as CEO. The Board of Directors has a...Read more
-
Johns Hopkins licensed technology receives $110 M investment
World | News | 0 Comment | 04 Jun, 2019
A pioneering blood test developed by Johns Hopkins researchers in the US, that makes cancer detection a part of routine medical care has received the largest investment ever for a Johns Hop...Read more
